tiprankstipranks
Trending News
More News >
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE

Ultragenyx Pharmaceutical (RARE) Similar Stocks

Compare
812 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ultragenyx Pharmaceutical
$36.66
$3.51B
-2.03%
13 Buy
1 Hold
0 Sell
Strong Buy
PTC Therapeutics
$50.85
$4.11B
7.97
42.76%
8 Buy
5 Hold
0 Sell
Moderate Buy
Crispr Therapeutics AG
$43.19
$3.59B
-28.69%
14 Buy
6 Hold
0 Sell
Moderate Buy
Zai Lab
$37.22
$4.65B
97.77%
6 Buy
1 Hold
0 Sell
Strong Buy
Springworks Therapeutics
$46.87
$3.53B
29.41%
1 Buy
5 Hold
0 Sell
Hold
Arcellx Inc
$64.09
$3.53B
16.86%
15 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RARE
Ultragenyx Pharmaceutical
36.66
-0.76
-2.03%
PTCT
PTC Therapeutics
50.85
15.23
42.76%
CRSP
Crispr Therapeutics AG
43.19
-17.38
-28.69%
ZLAB
Zai Lab
37.22
18.40
97.77%
SWTX
Springworks Therapeutics
46.86
10.65
29.41%
ACLX
Arcellx Inc
62.88
9.07
16.86%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis